Eisai appoints and promotes to manage MGI takeover
This article was originally published in Scrip
Executive Summary
Eisaihas made five appointments and six promotions at its Woodcliff Lake facility in New Jersey and its formulation R&D facility in Research Triangle Park in North Carolina.
Eisaihas made five appointments and six promotions at its Woodcliff Lake facility in New Jersey and its formulation R&D facility in Research Triangle Park in North Carolina.
The company has appointed Rosa Estrella senior counsel to provide legal support to its business development, strategic alliances and global medical and marketing services; Shawn Gallagher senior director of outsourced manufacturing operations; Kevin Chen associate director of biostatistics; Karen Parrish microbiologist IV at the Research Triangle Park facility; and Dr Tushar Patel associate director of scientific evaluation, business development.
Eisai has also promoted Vincent Andrews to associate general counsel; Robert Feeney to senior director, federal government relations; Lawrence Kristoff to associate director, materials management; Rad Mignerey to associate director, incentive compensation; and Mark Schwab to district manager, sales and marketing.
Eisai acquired MGI Pharma in January for $3.9 billion. The new appointments and promotions, which should not have any significant impact on its finances, are partly intended to enable Eisai to operate and manage its new acquisition, the company told Scrip. MGI boosted Eisai's net sales by 11% in its first quarter to ¥195.8 billion ($1.8 billion; ScripOnline, August 1st, 2008).